Prostatic Hypertrophy, Benign
11
2
2
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
38%
3 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (11)
Multicenter Randomized Controlled Trial of ThuLEP Versus ThuLEP Combined With Bladder Neck Incision in Patients With Small-Volume Benign Prostatic Hyperplasia
Study on the Effectiveness of Tranilast in the Treatment of Medium to Large Volume Benign Prostatic Hyperplasia
Assessing the Impact of the PVP With Greenlight Laser Using Prostatic MRI and Contrast-enhanced Ultrasound
Bipolar Needlescopic Enucleation Versus Vapoenucleation of BPH
Rezum I Pilot Study for Benign Prostatic Hyperplasia
Rezum FIM Optimization Study
Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
Medical Therapy of Prostatic Symptoms
Prostate Embolization for Acute Urinary Retention Study
Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices
Vardenafil in Greenlight(TM) Laser Surgery of Benign Prostate Hypertrophy